DESIPOC
Project Duration: September 2024 to August 2027
Latest from DESIPOC
16 - 17 October: Kick-Off Meeting
The kick-off meeting of DESIPOC was held on 16 - 17 October in Limassol, Cyprus. European Cancer Organisation staff travelled to meet the project consortium, to coordinate efforts and plan the work ahead. Representatives from the organisations involved in the project exchanged views and insights to develop the most effective strategies moving forward. ECO will play a crucial role in fostering synergies and cooperation within its extensive stakeholder network, as well as between DESIPOC and similar projects, in order to maximise their positive impact.
About DESIPOC
Cancer is the second leading cause of death worldwide, responsible for 1 in 6 deaths in 2018, according to the World Health Organization. As survival rates rise, more patients face the mental and emotional toll of the disease. Studies show distress, anxiety, and burnout are common and linked to higher mortality.
Europe must focus on addressing the mental health challenges of cancer patients and survivors – and it must do so urgently.
Screening tools exist, but inconsistent use, funding issues, workforce shortages and gaps in cross-border knowledge-sharing leave many vulnerable patients without the care they need and deserve.
DESIPOC aims to change that.
The project will create an innovative digital platform - the DESIPOC Virtual Observatory - focused on mental health support for cancer patients, carers, and healthcare professionals. This platform will enhance screening for depression, anxiety, and burnout while providing personalised interventions and remote monitoring.
It will also help policymakers understand and tackle the barriers to care. With pilot programmes in five EU countries (Cyprus, Greece, Lithuania, Romania, and Spain), DESIPOC is set to create a unified strategy, while considering national specificities.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.